Top Markets
Coin of the day
Wuhan Hiteck Biological Pharma Co.,Ltd Wuhan Hiteck Biological Pharma Co.,Ltd

Wuhan Hiteck Biological Pharma Co.,Ltd

300683
Rangering i aksjer #13466
Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise... Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye acyclovir tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository; Xunkeyuan tinidazole suppository; and Shufu nimodipine sustained-release tablets. Beyond therapeutics, Wuhan Hiteck also provides a comprehensive array of diagnostic kits. These include tests for measles virus and rubella virus nucleic acid, mycoplasma isolation and identification, bacterial vaginosis rapid detection, measles virus IgG antibodies, and the coronavirus N-protein. Furthermore, the firm supplies active pharmaceutical ingredients (APIs) and their chemical intermediates, notably Lopinavir and Ritonavir. Its core therapeutic areas of focus are the nervous system and oncology. Established in 1992, Wuhan Hiteck Biological Pharma Co.,Ltd is headquartered in Wuhan, China.
Aksjekurs
$3.71
Markedsverdi
$486.16M
Endring (1 dag)
-0.97%
Endring (1 år)
-45.64%
Land
CN
Handel Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

Kategori

Aksjeprishistorikk for Wuhan Hiteck Biological Pharma Co.,Ltd (300683)
Høyeste sluttskurs: $4.14 den 2026-08-01

Laveste sluttskurs: $9.02 den 2017-08-01
Aksjeprishistorikk for Wuhan Hiteck Biological Pharma Co.,Ltd fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 12.03%
2025 12.89%
2024 -29.37%
2023 -7.73%
2022 -31.14%
2021 20.37%
2020 60.25%
2019 2.10%
2018 -50.10%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$164.88 30.29%
DE
$37.61 25.11%
JP
$21.90 21.12%
IN
$218.36 25.22%
CH